Chemoinformaics analysis of TRIDEC-1-ENE-3-5-7-9-11-PENTAYNE
| Molecular Weight | 162.191 | nRot | 0 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 6 |
| Exact Molecular Weight | 162.047 | nRing | 0 |
| Solubility: LogS | -5.323 | nHRing | 0 |
| Solubility: LogP | 4.947 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 25.7108 |
| nHD | 0 | BPOL | 6.01924 |
| QED | 0.47 |
| Synth | 4.416 |
| Natural Product Likeliness | 2.028 |
| NR-PPAR-gamma | 0.87 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.03 |
| Pgp-sub | 0 |
| HIA | 0.966 |
| CACO-2 | -4.376 |
| MDCK | 0.000153708 |
| BBB | 0 |
| PPB | 1.05702 |
| VDSS | 1.244 |
| FU | 0.0295244 |
| CYP1A2-inh | 0.977 |
| CYP1A2-sub | 0.124 |
| CYP2c19-inh | 0.839 |
| CYP2c19-sub | 0.52 |
| CYP2c9-inh | 0.755 |
| CYP2c9-sub | 0.945 |
| CYP2d6-inh | 0.039 |
| CYP2d6-sub | 0.502 |
| CYP3a4-inh | 0.609 |
| CYP3a4-sub | 0.201 |
| CL | 7.227 |
| T12 | 0.077 |
| hERG | 0 |
| Ames | 0.389 |
| ROA | 0.866 |
| SkinSen | 0.979 |
| Carcinogencity | 0.296 |
| EI | 0.986 |
| Respiratory | 0.55 |
| NR-Aromatase | 0.978 |
| Antiviral | No |
| Prediction | 0.666352 |